Where we've
Come
Where we're
Headed
January
✳  BrainOne series of health supplements available at premium Lotte Duty Free stores
✳  Signed an industry-academia cooperation agreement with 20 universities across Korea
✳  Opened the Mediforum Experience Store at Lotte Duty Free's Flagship Location
✳  Deployed our new global English website to bring our products to the reach of a world wide audience
March
✳  Released APOE genotyping test kit for rapid genetic testing of APOE alleles in determining likelihood of developing Alzheimer's
✳  Designated as a Genetic Testing Agency by the Korean government (License No. 338)
✳  Deployed our new US based Ecommerce site for distribution and sales of natural supplements and health functional foods directly to customers based in the US
April
✳  Signed an agreement with the National Health Research Institutes of Taiwan for new drug development research
May
✳  Signed a Memorandum of Understanding with food and beverage distribution company Ikidia Co Ltd
✳  Released a new healthy energy tea series, BT21 Stir Berry Stick Vitamin Tea
✳  Presented a mass seminar with the Korea Biotechnology Industry Organization in regards to treatment of Alzheimer's
August
✳  Began sales of BrainOne Gold natural supplements for memory and brain health on Amazon
September
✳  Signed a Memorandum of Understanding with Inforyou Financial Services Co Ltd
✳  Signed a Memorandum of Understanding with Dankook University I-Dasan LINC+ Project Group, Dankook University Hospital (Triparite Technical Cooperation between Corporation, University and Hospital)
November
✳  Designated by the Korean government as a Leading Company to Overcome Dementia (No. 21-8-1-43-625)
April
✳  Deployed our Korean language US based Ecommerce site for sale of natural supplements and health functional foods directly to customers based in the US
June
✳  Partnered with the Korea Parkinson's Disease Association to conduct preliminary studies with BrainOne on individuals suffering from Parkinson's disease
August
✳  Began trial of BrainOne with 25 individuals with Parkinson's disease in conjunction with Korea Parkinson's Disease Association to evaluate positive impact on tremor, slow movement, muscle stiffness and blood clotting.
January
✳  Signed MOU and contracted with CRO (LSK Global Pharma Service) for PM-012 3rd phase clinical trial
✳  Launched premium synbiotics employing both probiotics and prebiotics, (Qurelac 1.2 Tera)
✳  Launched synbiotic lactic acid bacillus for dieting and weight-loss (Qurelac 2000)
February
✳  Obtained ISO13485:2016 certification
March
✳  Developed real time PCR screening for ApoE genotype, a genetic risk factor for dementia
✳  Certified as a genetic testing institution by the Korean CDC
✳  Started developing real time PCR testing kits for multiple STD screening
January
✳  Launched Eastern Health Functional Food for improving memory for women and treatment of Alzheimer's (Women's Myungmin Series)
March
✳  Launched rapid PCR genotyping test kit for identifying imported deer antler by breen and origin
✳  Launched Myungmin Series for improving memory and treatment of Alzheimer's
April
✳  Signed MOU for joint research with Shinwon Medical Foundation
May
✳  Launched online shopping mall for Eastern Medicine (Yakjaemadang) and began domestic sales
August
✳  Launched health functional food BrainOne, BrainOne Gold and Youth24 for memory improvement and commenced domestic distribution
✳  Signed a dealership agreement with Kuwait's M.Cure and exported Puräelle, a feminine foaming wash.
✳  Filed patent for the rapid PCR genotyping test kit for the identification of deer antler by country of origin and breed/subspecies. (Patent filing no. 10-2018-0221193)
September
✳  Phase 2b/3 clinical trials for PM-012 approved by Ministry of Food and Drug Safety
November
✳  Joint development of rapid PCR algae bloom diagnosis kit with Korea Water Resources Corporation
December
✳  Exported Q14, a cervical cancer screening kit to the clinical pathology center of molecular diagnostics tests in Poland
✳  Signed CRO outsourcing contract for MF-018, an investigational new drug, as a non-opioid treament for pain relief from chemotherapy (Synex Inc.)
January
✳  Investment and acquisition consultations with medical laboratories in the United States and Australia
✳  Began preparations for releasing feminine cleanser foaming wash, launched in May 2017
✳  Began preparations for releasing anti-dementia medicine and antidepressants, launched in April, 2017
February
✳  Initiated Eastern Medicine production (manufacture and sale of oriental medicine and health functional foods)
✳  Discussed business cooperation with Chinese firms Zhejiang Yongning Pharmaceuticals and Tiens Group
May
✳  Commenced production for feminine cleanser (Puräelle)
✳  Established Mediforum Eastern Medicine business (Jegi-dong, Dongdaemun-gu)
June
✳  Launched the manufacturing and sales of Eastern Medicine business
✳  Developed Myungminjae, an Eastern Medicine for brain function activiation
July
✳  Launched and eatablished distribution of Puräelle feminine cleanser foaming wash in Korea
November
✳  Exported Puräelle feminine cleanser foaming wash to Vietnam
December
✳  Launched Y-zone care for women, a feminine powder cream
February
✳  Established research lab and pharmaceutical manufacturing facility in Seongsu-dong
✳  Supplied reagent samples to the research center in Tianjin, China
March
✳  Signed a contract for licensing technology for new naturally derived drugs and acquired management from Puremed Inc.
June
✳  Completed 2nd clinical trial for rapid PCR cervical cancer (HPV) screening reagent
September
✳  Obtained ISO13485 certification from TUV Rhineland
October
✳  Implemented clinical trials at Ajou University and published results in international journals (Joined HPV Conference in Chicago, October 21, 2016)
November
✳  Selected as a representative in Europe for supplying medical equipment (EMERGO)
✳  Applied for CFS in the Netherlands
✳  Obtained KGMP certification from the Ministry of Food and Drug Safety
✳  Developed STD test kit and HPV rapid PCR test kit